Kurt Oreshack insider trades: Maravai Lifesciences Holdings (MRVI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kurt reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | MRVI | ↓ Sell10b5-1 | 50,000 | $5.08 | $254K | Direct | Jun 10, 2026 (0d) |
| Jan 31, 2025 | MRVI | ↓ Sell10b5-1 | 25,000 | $5.03 | $126K | Direct | Jan 31, 2025 (0d) |
| Nov 24, 2020 | MRVI | ↑ Buy | 7,500 | $27.00 | $203K | Direct | Nov 25, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRVI insiders
Open-market trades in the last 12 months
About Kurt Oreshack's insider trades
Kurt Oreshack is General Counsel at Maravai Lifesciences Holdings (MRVI). Since Nov 24, 2020, Kurt has reported 1 open-market purchase worth $203K and 2 sales worth $380K on SEC Form 4. In the last 12 months: 1 sale ($254K).
2 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (11 filings), shares withheld for taxes (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRVI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.